Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ZALTRAP Special Drug Use Surveillance (Unresectable advanced and/or recurrent colorectal cancer)

Next Previous
Trial Profile

ZALTRAP Special Drug Use Surveillance (Unresectable advanced and/or recurrent colorectal cancer)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Sep 2018

At a glance

  • Drugs Aflibercept (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ZALTRAP
  • Sponsors Sanofi K.K.

    • Most Recent Events

    • 15 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 03 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top